AYR Wellness Announces Filing of Q1 2025 Interim Financial Statements and MD&A

Core Insights - AYR Wellness Inc. has filed its unaudited interim condensed consolidated financial statements for Q1 2025, ending March 31, 2025 [1] - The financial statements and Management's Discussion and Analysis (MD&A) are available for review on SEDAR+ and the SEC's EDGAR system [2] - Shareholders and interested parties are encouraged to review the filed materials for comprehensive information regarding the Company's operating performance and liquidity position [3] Non-GAAP Measures - The Company reports non-GAAP measures to evaluate business performance and manage capital structure, which may not be comparable to similar measures from other issuers [4] - Non-GAAP measures such as "Adjusted EBITDA" and "Adjusted Gross Profit" are provided to complement GAAP measures and offer further understanding of operational results [5][6] - Adjusted EBITDA is defined as income from continuing operations before interest and taxes, adjusted for non-core costs and non-cash items [7] - Adjusted Gross Profit represents gross profit adjusted for certain costs, including interest and depreciation, with reconciliations provided in the MD&A [8] Company Overview - AYR Wellness is a vertically integrated U.S. multi-state cannabis operator with over 90 licensed dispensaries and a portfolio of cannabis CPG brands [11] - The Company aims to deliver high-quality cannabis products while positively impacting its team members and the communities it serves [11]